These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 20816903
1. Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B). Shearer JD, Vassar ML, Swiderski W, Metcalfe K, Niemuth N, Henderson I. Vaccine; 2010 Oct 21; 28(45):7313-8. PubMed ID: 20816903 [Abstract] [Full Text] [Related]
2. Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity. Khouri JM, Motter RN, Arnon SS. Vaccine; 2018 Apr 05; 36(15):2041-2048. PubMed ID: 29475762 [Abstract] [Full Text] [Related]
3. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system. Yu Y, Shi D, Liu S, Gong ZW, Wang S, Sun Z. Hum Vaccin Immunother; 2015 Apr 05; 11(2):468-73. PubMed ID: 25483668 [Abstract] [Full Text] [Related]
4. Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B). Shearer JD, Manetz TS, House RV. Vaccine; 2012 Mar 02; 30(11):1917-26. PubMed ID: 22269871 [Abstract] [Full Text] [Related]
5. Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library. Yu R, Wang S, Yu YZ, Du WS, Yang F, Yu WY, Sun ZW. J Biomol Screen; 2009 Sep 02; 14(8):991-8. PubMed ID: 19726786 [Abstract] [Full Text] [Related]
6. Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms. Zhao H, Nakamura K, Kohda T, Mukamoto M, Kozaki S. Jpn J Infect Dis; 2012 Sep 02; 65(2):138-45. PubMed ID: 22446121 [Abstract] [Full Text] [Related]
7. Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model. Tomic MT, Farr-Jones S, Syar ES, Niemuth N, Kobs D, Hackett MJ, Espinoza Y, Martinez Z, Pham K, Snow DM, Marks JD, Cobb RR. Toxins (Basel); 2021 Sep 21; 13(9):. PubMed ID: 34564675 [Abstract] [Full Text] [Related]
12. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D. Moreira C, da Cunha CE, Moreira GM, Mendonça M, Salvarani FM, Moreira ÂN, Conceição FR. Anaerobe; 2016 Aug 21; 40():58-62. PubMed ID: 27236078 [Abstract] [Full Text] [Related]
13. Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex. Sahay B, Colliou N, Zadeh M, Ge Y, Gong M, Owen JL, Valletti M, Jobin C, Mohamadzadeh M. Vaccine; 2018 Jan 02; 36(1):155-164. PubMed ID: 29180028 [Abstract] [Full Text] [Related]
14. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model. Tomic MT, Espinoza Y, Martinez Z, Pham K, Cobb RR, Snow DM, Earnhart CG, Pals T, Syar ES, Niemuth N, Kobs DJ, Farr-Jones S, Marks JD. Toxins (Basel); 2019 Apr 06; 11(4):. PubMed ID: 30959899 [Abstract] [Full Text] [Related]
15. Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles. Ruwona TB, Xu H, Li J, Diaz-Arévalo D, Kumar A, Zeng M, Cui Z. Hum Vaccin Immunother; 2016 May 03; 12(5):1188-92. PubMed ID: 26837242 [Abstract] [Full Text] [Related]
16. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F. Yu YZ, Zhang SM, Ma Y, Zhu HQ, Wang WB, Du Y, Zhou XW, Wang RL, Wang S, Yu WY, Huang PT, Sun ZW. Clin Immunol; 2010 Nov 03; 137(2):271-80. PubMed ID: 20696619 [Abstract] [Full Text] [Related]